GILEAD SCIENCES, INC. Accrued Income Taxes, Current
GILEAD SCIENCES, INC. (GILD) had Accrued Income Taxes, Current of $92.00 million as of 2025-12-31, per its 10-K filed 2026-02-24.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current › Accrued Liabilities, Current
us-gaap:AccruedIncomeTaxesCurrent · last filed 2026-02-24
- 2025-12-31: Accrued Income Taxes, Current $92.00M.
- 2024-12-31: Accrued Income Taxes, Current $1.65B.
- 2024-09-30: Accrued Income Taxes, Current $1.54B.
- 2024-06-30: Accrued Income Taxes, Current $1.26B.
| Period end | Accrued Income Taxes, Current | Accrued Income Taxes, Current as first filed |
|---|---|---|
| 2025-12-31 | $92.00M 10-K · filed 2026-02-24 | |
| 2024-12-31 | $1.65B 10-K · filed 2026-02-24 | |
| 2024-09-30 | $1.54B 10-Q · filed 2024-11-12 | |
| 2024-06-30 | $1.26B 10-Q · filed 2024-08-08 | |
| 2024-03-31 | $1.20B 10-Q · filed 2024-05-08 | |
| 2023-12-31 | $1.21B 10-K · filed 2025-02-28 | |
| 2023-09-30 | $2.09B 10-Q · filed 2023-11-07 | |
| 2023-06-30 | $2.23B 10-Q · filed 2023-08-04 | |
| 2023-03-31 | $1.14B 10-Q · filed 2023-05-03 | |
| 2022-12-31 | $959.00M 10-K · filed 2024-02-23 | |
| 2022-09-30 | $902.00M 10-Q · filed 2022-11-02 | |
| 2022-06-30 | $902.00M 10-Q · filed 2022-08-08 | |
| 2022-03-31 | $467.00M 10-Q · filed 2022-05-04 | |
| 2021-12-31 | $539.00M 10-K · filed 2023-02-22 | |
| 2021-09-30 | $447.00M 10-Q · filed 2021-11-03 | |
| 2021-06-30 | $439.00M 10-Q · filed 2021-08-05 | |
| 2021-03-31 | $215.00M 10-Q · filed 2021-05-06 | |
| 2020-12-31 | $598.00M 10-K · filed 2022-02-23 | |
| 2020-09-30 | $943.00M 10-Q · filed 2020-11-04 | |
| 2020-06-30 | $911.00M 10-Q · filed 2020-08-06 | |
| 2020-03-31 | $645.00M 10-Q · filed 2020-05-06 | |
| 2019-12-31 | $287.00M 10-K · filed 2021-02-25 | |
| 2018-12-31 | $190.00M 10-K · filed 2020-02-25 | |
| 2018-09-30 | $17.00M 10-Q · filed 2018-11-06 | |
| 2018-06-30 | $17.00M 10-Q · filed 2018-08-06 | |
| 2018-03-31 | $66.00M 10-Q · filed 2018-05-09 | |
| 2017-12-31 | $713.00M 10-K · filed 2019-02-26 | |
| 2016-12-31 | $186.00M 10-K · filed 2018-02-27 | |
| 2016-09-30 | $390.00M 10-Q · filed 2016-11-07 | |
| 2016-03-31 | $51.00M 10-Q · filed 2016-05-06 | |
| 2015-12-31 | $65.00M 10-Q · filed 2016-11-07 | |
| 2015-09-30 | $159.00M 10-Q · filed 2015-11-04 | |
| 2015-06-30 | $356.00M 10-Q · filed 2015-08-05 | |
| 2015-03-31 | $98.00M 10-Q · filed 2015-05-08 | |
| 2014-12-31 | $105.00M 10-K · filed 2016-02-24 | |
| 2014-09-30 | $43.78M 10-Q · filed 2014-11-05 | |
| 2014-06-30 | $97.30M 10-Q · filed 2014-08-04 | |
| 2014-03-31 | $152.95M 10-Q · filed 2014-05-07 | |
| 2013-12-31 | $11.00M 10-K · filed 2015-02-25 | $10.86M 10-K · filed 2014-02-25 |
| 2013-09-30 | $10.65M 10-Q · filed 2013-10-31 | |
| 2013-06-30 | $37.97M 10-Q · filed 2013-08-01 | |
| 2013-03-31 | $19.24M 10-Q · filed 2013-05-08 | |
| 2012-12-31 | $13.40M 10-K · filed 2014-02-25 | |
| 2012-09-30 | $17.09M 10-Q · filed 2012-11-06 | |
| 2012-06-30 | $11.85M 10-Q · filed 2012-08-01 | |
| 2012-03-31 | $14.49M 10-Q · filed 2012-05-04 | |
| 2011-12-31 | $40.58M 10-K · filed 2013-02-27 | |
| 2011-09-30 | $33.67M 10-Q · filed 2011-11-04 | |
| 2011-06-30 | $5.44M 10-Q · filed 2011-08-05 | |
| 2011-03-31 | $2.46M 10-Q · filed 2011-05-09 | |
| 2010-12-31 | $1.86M 10-K · filed 2012-02-23 | |
| 2010-09-30 | $38.71M 10-Q · filed 2010-11-08 | |
| 2010-06-30 | $24.36M 10-Q · filed 2010-08-09 | |
| 2010-03-31 | $38.49M 10-Q · filed 2010-05-10 | |
| 2009-12-31 | $167.62M 10-K · filed 2011-02-28 | |
| 2009-09-30 | $139.54M 10-Q · filed 2009-11-05 | |
| 2009-06-30 | $73.39M 10-Q · filed 2009-08-05 | |
| 2008-12-31 | $44.76M 10-K · filed 2010-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AMGEN INC (AMGN) | United States | $219.567B | 22.39 |
| Moderna, Inc. (MRNA) | United States | $77.819B | -8.86 |
| Revolution Medicines, Inc. (RVMD) | United States | $42.805B | -22.69 |
| BIOGEN INC. (BIIB) | United States | $33.427B | 19.60 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |